Three decades after the first Transcatheter Cardiovascular Therapeutics conference, TCT.18’s organizers are moving “toward a more practical approach,” says Cardiovascular Research Foundation CEO Juan Granada, MD.
Mergers are a lot like arranged marriages in that there’s little or no opportunity for the parties to build relationships before their union is finalized. Building a united team requires much more than a mandate from leadership.
As healthcare shifts from fee-for-service to value-based payment models, practices are experimenting with different ways to measure physicians’ contributions to their practices. Will time value units (TVUs) one day replace relative value units (RVUs)?
With its potential to tap into a myriad of hospital services and departments, hypertrophic cardiomyopathy is drawing interest from medical centers committed to improving the lives of their patients and bolstering the bottom line.
Troponin has become a widely accepted cardiac biomarker for myocardial infarction patients admitted to emergency rooms. But just how reliable is troponin in determining if a heart attack is really a heart attack?
The entry of new players and dozens of potentially disruptive mergers and acquisitions are pushing healthcare in nontraditional directions, yielding opportunities for cardiologists to help shape the transformation.